These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32222455)

  • 21. Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?
    Kara C; Şen EM; Elgin KU; Serdar K; Yilmazbaş P
    Int Ophthalmol; 2017 Jun; 37(3):619-626. PubMed ID: 27506567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
    Kalouche G; Beguier F; Bakria M; Melik-Parsadaniantz S; Leriche C; Debeir T; Rostène W; Baudouin C; Vigé X
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1816-25. PubMed ID: 27082296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM;
    Am J Ophthalmol; 2003 Jan; 135(1):55-63. PubMed ID: 12504698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.
    Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5182-8. PubMed ID: 14638715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin analog treatment of glaucoma and ocular hypertension.
    Alexander CL; Miller SJ; Abel SR
    Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma.
    Ussa F; Fernandez I; Brion M; Carracedo A; Blazquez F; Garcia MT; Sanchez-Jara A; De Juan-Marcos L; Jimenez-Carmona S; Juberias JR; Martinez-de-la-Casa JM; Pastor JC
    Ophthalmology; 2015 May; 122(5):1040-8.e4. PubMed ID: 25704319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA; Kelly CR; Crider JY
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost.
    Kurtz S; Mann O
    Eur J Ophthalmol; 2009; 19(3):400-3. PubMed ID: 19396785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK; Palmberg P; Sheu WP;
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.
    Dirks MS; Noecker RJ; Earl M; Roh S; Silverstein SM; Williams RD
    Adv Ther; 2006; 23(3):385-94. PubMed ID: 16912020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments.
    Bahler CK; Howell KG; Hann CR; Fautsch MP; Johnson DH
    Am J Ophthalmol; 2008 Jan; 145(1):114-9. PubMed ID: 17988642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Switching From Latanoprost to Bimatoprost in Primary Open-Angle Glaucoma Patients Who Experienced Intraocular Pressure Elevation During Treatment.
    Germano RA; Susanna R; De Moraes CG; Susanna BN; Susanna CN; Chibana MN
    J Glaucoma; 2016 Apr; 25(4):e359-66. PubMed ID: 26900825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on bimatoprost in glaucoma therapy.
    Cantor LB
    Expert Opin Pharmacother; 2002 Dec; 3(12):1753-62. PubMed ID: 12472372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.